← CA Feed

PharmaTher Collaborates with Craft Health to Evaluate CraftMake(TM) GMP-Ready Pharmaceutical 3D Printing Platform for Personalized Peptides

Source Summary

Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) ("PharmaTher" or the "Company"), a specialty pharmaceutical company focused on personalized medicines, announced today a collaboration with Craft Health Pte. Ltd. ("Craft Health") to evaluate Craft Health's CraftMakeTM GMP-ready pharmaceutical 3D printing platform for PharmaTher's Personaliz3D PeptidesTM partner ecosystem. The collaboration will focus on developing novel pe

Advertisement
Read Original Article